Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva lanza oferta por Mylan de US$82 por acción
Teva Tries to Put an End to the Opioid Wars - WSJ
With Teva Bid Off the Table, Mylan's Stock In 'Show-Me' Mode - WSJ
Teva faces fresh shareholder showdown over management structure | Financial Times
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Teva, denying 'any liability,' set aside $646M for opioid settlements. Here's why | Fierce Pharma
La farmacéutica Teva ofrece US$40.000 millones por Mylan - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
WSJ Print Edition a l'App Store
Israeli drug manufacturer Teva at center of anti-trust lawsuit brought by 44 states - Jewish Telegraphic Agency
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Una aplicación permite leer el Wall Street Journal sin pagar – Albert Cuesta
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
FDA's Call on Migraine Drug Could Be Trouble for Teva | Barron's
Teva Part of Consortium Looking to Participate in Purdue Pharma's Bankruptcy, Report Says | Ctech
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Tries to Put an End to the Opioid Wars - WSJ
The Wall Street Journal' preveu "l'acceleració" de la ruptura entre Catalunya i Espanya
Drug Distributors and Teva Reach Settlement in Ohio Opioid Litigation - WSJ
